Functional Skills

Business Planning
Market Research
Financial Modeling
CRM Selection / Implementation
Compensation Strategy

Software Skills

Salesforce
Oracle CRM

Sector Experience

Healthcare
Manufacturing
Life Sciences & Pharma
9
years

Years of Experience

8/21

Member Since


Experience

 
BENUVIA MANUFACTURING Sales
Director Pharmaceutical BD
02/2021 - 05/2021
Consultant for 4 months

Catalent Sales
Director BD
01/2020 - 08/2020
Covering 10 state Midwest geography selectively channeling Solid Oral Dose formulation, product development and manufacturing to 5 NAM sites and 2 UK sites. Schedule I – V drugs and potent compounds, pre-clinical to Phase 2.

Nitto Avecia Sales
BD Manager
02/2018 - 10/2018
GMP and CMC laboratory services to support pharmaceutical development; method development, validation, stability, formulation, batch release and extractables / leachables. Additionally, sold GMP aseptic sterile manufacturing, for liquid and lyophilization products. Batch sizes less than 50,000. Controlled Drug Schedule II – V. Covering 15 states in the Southeast USA.

Intertek Sales
BDM
02/2017 - 02/2018
Limited GMP and CMC laboratory services to support pharmaceutical development. This role was for the New Jersey site only, and focused on Elemental Impurities, including extractables / leachable. Method development for validation and stability, as it applied to early pre-clinical chemistry. The facility addressed Controlled Drug Schedule II – V. Covering 15 states in the Southeast USA.


Sharp Packaging Sales
Account Executive
02/2016 - 10/2017
Full service clinical CDMO for Phase I, II, and III clients, providing contract clinical supply materials. Services include - solid dose formulation, placebo manufacturing, tableting, capsuling, over-encapsulating, various packaging scenarios including blistering, labeling, kitting, storage, distribution, logistics and IRT. Controlled Drug Schedule II – V. Territory defined as central and southeast USA representing 27 states.

SGS Sales
BDM
05/2011 - 02/2016
R&D and Quality Control contract analytical testing. Responsible for all pharmaceutical, biopharmaceutical and medical device accounts in 13 state southeastern US geography for a $6 Billion multinational corporation with 5 North American laboratories. Controlled Drug Schedule I – V. Customer profiles include API through Finished Product and include all aspects of drug development requirements from pre-clinical testing to commercialization.